Engen Biotech
KOSDAQ · Healthcare · 149억원
₩2,370+29.86%
Price
4798.0원
2370.0원
Apr 27, 26Jul 22, 26
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue₩12.0B+0.2%
Operating Income-₩1.6B+17.7%
Net Income-₩4.2BTurned to loss
12/'25 vs prev quarter
Company Health
Operating Margin-25.0%
Cash on Hand30억원
PSR0.5x
PBR0.7x
ROE-35.7%
Short Volume0.0%as of 26.07.22